William Bertrand
2018
In 2018, William Bertrand earned a total compensation of $1.3M as Chief Operating Officer at Adaptimmune Therapeutics, a 35% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $159,120 |
|---|---|
| Option Awards | $685,114 |
| Salary | $416,000 |
| Other | $33,403 |
| Total | $1,293,637 |
Bertrand received $685.1K in option awards, accounting for 53% of the total pay in 2018.
Bertrand also received $159.1K in non-equity incentive plan, $416K in salary and $33.4K in other compensation.
Rankings
In 2018, William Bertrand's compensation ranked 7,904th out of 14,244 executives tracked by ExecPay. In other words, Bertrand earned more than 44.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,904 out of 14,244 | 45th |
Division Manufacturing | 3,093 out of 5,765 | 46th |
Major group Chemicals And Allied Products | 1,157 out of 2,128 | 46th |
Industry group Drugs | 973 out of 1,817 | 47th |
Industry Biological Products, Except Diagnostic Substances | 185 out of 339 | 45th |
Pay ratio
| William Bertrand's Pay | $1,293,637 |
|---|---|
| Median Employee's Pay | $137,800 |
| Pay Ratio | 9to 1 |
In 2018, the annual total compensation of William Bertrand was $1,293,637.
The annual total compensation of the median employee at Adaptimmune Therapeutics was $137,800.
The ratio of William Bertrand's pay to the pay of median employee was therefore 9 to one.
Source: SEC filing on March 15, 2019.
Bertrand's colleagues
We found four more compensation records of executives who worked with William Bertrand at Adaptimmune Therapeutics in 2018.